Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|1757-4676|10|1267-1284

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.1757-4676, Iss.10, 2015-10, pp. : 1267-1284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis

By  

EMBO Molecular Medicine, Vol. 7, Iss. 10, 2015-10 ,pp. : 1267-1284

John Wiley & Sons Inc

Access to resources Recommend Favorite

VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin‐1+ monocyte/TGF‐β1 paracrine axis

By  

EMBO Molecular Medicine, Vol. 1757-4676, Iss. 10, 2015-10 ,pp. : 1366-1384

John Wiley & Sons Inc

Access to resources Recommend Favorite

VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin‐1+ monocyte/TGF‐β1 paracrine axis

By  

EMBO Molecular Medicine, Vol. 7, Iss. 10, 2015-10 ,pp. : 1366-1384

John Wiley & Sons Inc

Access to resources Recommend Favorite

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

By  

EMBO Molecular Medicine, Vol. 10, Iss. 2, 2018-02 ,pp. : 219-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase‐1 and ‐2

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 1214-1219

John Wiley & Sons Inc

Access to resources Recommend Favorite